Squarepoint Ops LLC Monte Rosa Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.38 - $7.86 $76,607 - $178,146	22,665 New	22,665 $84,000
Q4 2023 Feb 14, 2024	BUY	$2.5 - $5.93 $43,655 - $103,549	17,462 New	17,462 $98,000
Q1 2023 May 15, 2023	BUY	$5.95 - $8.21 $83,288 - $114,923	13,998 New	13,998 $109,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $93,984 - $159,393	13,108 Added 85.66%	28,410 $232,000
Q2 2022 Aug 15, 2022	BUY	$6.15 - $14.99 $94,107 - $229,376	15,302 New	15,302 $148,000
Q3 2021 Nov 15, 2021	SELL	$18.59 - $42.21 $524,405 - $1.19 Million	-28,209 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.86 - $22.7 $532,021 - $640,344	28,209 New	28,209 $640,000

44.1M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $315M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.